Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 8th TPD & Induced Proximity Summit.

Trailblazing Academic Leaders
Founders & C-Level Leaders
Biopharma Industry Leaders
Pioneering Partner Speakers

Trailblazing Academic Leaders

Craig Crews

Prof.
Yale University

Eric Fisher

Director & Professor
DFCI Center for Protein Degradation & Harvard Medical School

Victor Guallar

Chief Scientific Officer
Barcelona Supercomputing Center

Katherine Donovan

Lead Scientist / Managing Director-Fischer labs
Dana Farber Cancer Institute

Christina Woo

Professor of Chemistry and Chemical Biology
Harvard University

Zoran Rankovic

Professor of Chemical Biology, and Director of the Centre for Protein Degradation
Institute of Cancer Research

Tinghu Zhang

Senior Scientist, Gray Labs
Stanford University

HONG-YU Li

prof
Health Science Center at San Antonio

Founders & C-Level Leaders

Ray Deshaies

Director/Advisor/Consultant
Amgen Inc.

Noah Berkowitz

Chief Medical Officer
Arvinas, Inc.

Arthur T. Sands

Chief Executive Officer
Nurix Therapeutics, Inc.

Gwenn Hansen

Chief Scientific Officer
Nurix Therapeutics, Inc.

Andrew Hirsch

President & Chief Executive Officer
C4 Therapeutics Inc

Antony Mattessich

CEO
Amphista Therapeutics

Louise Modis

CSO
Amphista Therapeutics

Eyal Attar

Chief Medical Officer
Halda Therapeutics

Greg Verdine

CEO
LifeMine Therapeutics

Neil Torbett

CEO
PhoreMost

Benedict Cross

Chief Technology Officer
PhoreMost

Adam Davenport

Chief Discovery Officer
Proxygen GmbH

Steven Bellon

Chief Scientific Officer
Foghorn Therapeutics

Joey Azofeifa

CEO
Arpeggio Bio

Dong Kim

Chief Executive Officer
AevisBio Inc.

Kate Yen

CEO
Auron Therapeutics
David Millan

David Millan

Chief Scientific Officer
Auron Therapeutics

Randolph Lopez

CTO
A-Alpha Bio Inc.

Zachary Rosenthal

CEO/Founder
Birdwood Therapeutics

Yong Cang

Chief Scientific Officer & Co-founder
Degron Therapeutics

Simon Glerup

CSO
Draupnir Bio Aps

Guangdi Wang

Chief Executive Officer
EndoTarget

Shyra Gardai

Chief Scientific Officer
EpiBiologics

Anna Rivkin

Chief Business Officer
Foghorn Therapeutics

ANITA BELLAIL

president
HB Therapeutics, Inc.

Lawrence Hamann

Co-founder and CEO
Interdict Bio

Krista Goodman

CSO
Larkspur Biosciences

Nan Ji

CEO
PAQ Therapeutics

Hyunsun Jo

Founder, CEO
Pin Therapeutics

Brent Meadows

Chief Business Officer
Polymed Biopharmaceuticals

Dominic Reynolds

CSO
Remix Therapeutics

Giovanni Spagnolli

CTO
Sibylla Biotech srl

Scott Kanner

Associate Director - Platform Development
Stablix

Arnout Schepers

CEO
TenAces Biosciences

Chris Tame

Founder & Chief Executive Officer
Ternary Therapeutics

Nicki Thompson

CEO
Trimtech Therapeutics

Robert Hromas

Dean
Dialectic Therapeutics

Henrik Daub

Chief Scientific Officer
NEOsphere Biotechnologies GmbH

Biopharma Industry Leaders

Ryan Potts

Vice President, Research
Amgen Inc.

Juliet Williams

Head Of Research
Kymera Therapeutics

Mark Noviski

Associate Director - Cell Biology & Project Lead
Nurix Therapeutics, Inc.

Matthew Sowa

Vice President of Lead Discovery
C4 Therapeutics

Chris Nasveschuk

Senior Vice-President of Chemical Sciences
C4 Therapeutics Inc

Christopher O’Donnell

Executive Director & Vice President - Business Development, Emerging Sciences & Innovation, Partner
Pfizer

David Barrett

Engineered Small Molecules, Oncology Research Head (Esm)
Astellas Pharma

Matthew Hayward

Vice President of Drug Discovery
Magnet Biomedicine

Aly Jackson

Business Development Leader
Genentech

Ian Churcher

CEO & Founder
Janus Drug Discovery Consulting Ltd

Qi Wan

Principal Scientist
Abbvie

Rene Lemieux

SVP & Head of Research
Avilar Therapeutics

Esther Lee

Associate Director of Medicinal Chemistry
AstraZeneca

Changhoon Ji

Executive Director
AUTOTAC Bio

Catherine Henry

Associate Director, Preclinical R&D
Cullinan Oncology

Jing Liu

Senior Vice President
Cullgen Inc.

WU DU

SVP
Hinova Pharmaceuticals

Maureen Galmes-Spit

Vice President Research
Laigo Bio

Morgan O’Shea

Medicinal Chemist
Larkspur Biosciences

Minoru Tanaka

Director
Mitsubishi Tanabe Pharma

Lingling Shen

Associate Director of Data Sciences
Novartis AG

Markus Haeberlein

EVP
Parabilis Medicines

Takeru Furuya

Principal
Perceptive Advisors LLC

Feng Wang

Senior Principal Scientist & Head of Protein Homeostasis Group
Pfizer

Prakash Palde

Director - Biophysics, High Throughput Screening & Oncology
Pfizer

Andrew Burritt

Senior Director of Chemistry
Plexium Inc.

Peggy Thompson

Vice President, Head of Biology
Plexium Inc.

Koichi Ito

Senior Director
Prelude Therapeutics​

Jack Carter

Director
Prelude Therapeutics​

Rick Ewing

VP, Chemistry
Rapafusyn Pharmaceuticals

Derek Taylor

Head of Structural Biology (Rappta Therapeutics); Professor (Case Western Reserve University)
Case Western Reserve University

Sanjiv Shah

Executive Director - Discovery Science
Revolution Medicines

Nicholas Endres

Senior Principal Scientist
Genentech

Xiaoqi Liu

Head of Business Development & Strategic Finance
Degron Therapeutics

Joshua Murtie

Vice President - Biology
Photys Therapeutics

Kristin Riching

R&D Group Leader
Promega Corporation

Michael Drummond

Principal Scientist
Chemical Computing Group

Greg Parker

Senior Director - Biology
Plexium Inc.

Pioneering Partner Speakers

Henrik Daub

Chief Scientific Officer
NEOsphere Biotechnologies GmbH
Join Biopharma Experts
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights on the TPD innovations during our packed agenda, interactive roundtables, and new CCOs & VC panel discussions.

View Presentations & Speakers
Partner With Us
Partner With Us

Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.

Explore Sponsorship Options
Explore the Agenda
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now